Full text
| |
| Author(s): |
Érica Aparecida de Oliveira
Total Authors: 1
|
| Document type: | Doctoral Thesis |
| Press: | São Paulo. |
| Institution: | Universidade de São Paulo (USP). Instituto de Pesquisas Energéticas e Nucleares (IPEN/BT) |
| Defense date: | 2014-11-04 |
| Examining board members: |
Bluma Linkowski Faintuch;
Raquel Chacon Ruiz Martinez;
Ana Maria Moro;
Nanci do Nascimento;
Maria Teresa de Carvalho Pinto Ribela
|
| Advisor: | Bluma Linkowski Faintuch |
| Abstract | |
Molecular imaging offers the prospect of detecting diseases well before the symptoms appear. The tumor vasculature is vital in the tumor growth and dissemination of metastasis, thus some radiopharmaceuticals are directed to angiogenesis. The glioma, a brain tumor of low incidence but high mortality, requires an early diagnosis for favoring therapeutic approaches. The aim of this study was the development of a new radiopharmaceutical for imaging diagnosis of glioma, based in angiogenic peptides (GX1 and RGD-GX1) radiolabeled with technetium-99m radioisotope. The peptidic conjugates showed very similar performance in several evaluation. They were radiolabeled with high radiochemical purity (>96%) and are stable in the blood serum at least for four hours. Both are hydrofilic and had minimal binding to plasma protein. The biodistribution in healthy mice at many times, showed high renal excretion and fast blood clearance for both radiotracers. At in vitro studies, the 99mTc-HYNIC-PEG4-c(GX1) exhibit binding peaks at 60 min and the 99mTc-HYNIC-E-[c(RGDfk)-c(GX1)]) at 120 min, at HUVEC endotelial cells, used as control, and at tumor cell lines U87MG and T98G. The animal tumor uptake was more pronounced for U87MG cells, specially for 99mTc-HYNIC-E-[c(RGDfk)-c(GX1)]) (2.87 ± 0.53% DI/g) at 60 min p.i., with good visualization in images acquired with gama-camara and micro-SPECT/CT. Studies performed with peptides conjugate to magnetonanoparticles for MRI visualization also demonstred the peptides specificity in tumor tissue.The 99mTc-HYNIC-E-[c(RGDfk)-c(GX1)]) performance was superior to the GX1 tracer, regarding the glioma uptake, and may be consider as a promisser radiopharmaceutical for glioma diagnosis. (AU) | |
| FAPESP's process: | 11/12405-0 - DEVELOPMENT OF ANGIOGENIC RADIOTRACER FOR GLIOMA DIAGNOSE: AN ANIMAL MODEL STUDY |
| Grantee: | Érica Aparecida de Oliveira |
| Support Opportunities: | Scholarships in Brazil - Doctorate |